Javascript is required for this site to function, please enable.
Page:  
1. Section 1: General questions Please name the country you are a representative of.
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponseCount
[ShowReplies]34

2. Section 2: Establishing legal, institutional and financial frameworks Has your country established legal and institutional frameworks to support implementation of the provisions of the Aarhus Convention in the context of GMOs, the Almaty Amendment on GMOs and Article 23 of the Cartagena Protocol on Biosafety ?
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponsePercentResponseCount
Yes
61.8%21
Yes, to a limited extent
17.6%6
No
20.6%7

3. Has your country established financial frameworks to support implementation of the provisions of the Aarhus Convention in the context of GMOs, the Almaty Amendment on GMOs and Article 23 of the Cartagena Protocol on Biosafety?
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponsePercentResponseCount
Yes
38.2%13
Yes, to a limited extent
29.4%10
No
32.4%11
Comment
[ShowReplies]
1

4. Based on your experience, what do you consider as representing the greatest challenges for ensuring public access to information regarding LMOs/GMOs, including raw data? Please rank them by selecting their importance:
 AnsweredQuestion33
 
SkippedQuestion
4
Importance of the Challenge
 
High ImportanceMedium ImportanceLow ImportanceResponseCount
Lack of availability of objective information51.5% (17)21.2% (7)27.3% (9)33
Lack of monitoring systems50.0% (16)37.5% (12)12.5% (4)32
Confidentiality of information15.6% (5)37.5% (12)46.9% (15)32
Lack of LMOs/GMOs labelling provision31.3% (10)21.9% (7)46.9% (15)32
Lack of data collection system43.8% (14)28.1% (9)28.1% (9)32
Other (please specify)
[ShowReplies]
11

5. Section 4: Public participation in decision-making Has your country established a mechanism to ensure public participation in the decision-making processes regarding LMOs/GMOs?
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponsePercentResponseCount
Yes
55.9%19
Yes, to a limited extent
26.5%9
No
17.6%6

6. Has your country taken any initiative on the following aspects of public participation in the decision-making processes in the last three years?
 AnsweredQuestion34
 
SkippedQuestion
3
 
YesYes, to a limited extentNoResponseCount
a) Enabling the public to submit comments, information, analyses or opinions that it considers relevant to the proposed deliberate release, including placing on the market, in any appropriate manner.55.9% (19)20.6% (7)23.5% (8)34
b) Ensuring that when decisions regarding LMOs/GMOs are made, due account is taken of the outcome of the public participation procedure.58.8% (20)23.5% (8)17.6% (6)34
c) Ensuring that decisions regarding LMOs/GMOs are made publicly available along with the reasons and considerations upon which it is based.63.6% (21)15.2% (5)21.2% (7)33

7. Section 5: Access to justice Has your country established a mechanism to ensure access to justice regarding LMOs/GMOs?
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponsePercentResponseCount
Yes
64.7%22
Yes, to a limited extent
17.6%6
No
17.6%6

8. Based on your experience what do you consider as representing the biggest challenges for providing greater access to justice regarding LMOs/GMOs? Please rank them by selecting their importance. List:
 AnsweredQuestion33
 
SkippedQuestion
4
Importance of the Challenge
 
High ImportanceMedium ImportanceLow ImportanceResponseCount
Adequate and effective remedies (e.g. administrative or judicial review or appeals procedures operated by public authorities, courts, tribunals, ombudsperson)62.5% (20)15.6% (5)21.9% (7)32
Cost40.6% (13)34.4% (11)25.0% (8)32
Standing (the right of an individual or entity to go to court)41.9% (13)29.0% (9)29.0% (9)31
Experience of judges40.6% (13)37.5% (12)21.9% (7)32
Other (please specify)
[ShowReplies]
9

9. Section 6: Priorities for the future work What do you believe should be future priorities to support the effective implementation of the provisions of the Aarhus Convention in the context of GMOs, its Almaty amendment on GMOs and Article 23 of the Cartagena Protocol on Biosafety?
 AnsweredQuestion34
 
SkippedQuestion
3
Importance of the Challenge
 
High ImportanceMedium ImportanceLow ImportanceResponseCount
Country-specific projects54.5% (18)30.3% (10)15.2% (5)33
Capacity building events at regional and subregional levels58.8% (20)32.4% (11)8.8% (3)34
Capacity building events at global level33.3% (11)36.4% (12)30.3% (10)33
Awareness-raising campaigns57.6% (19)30.3% (10)12.1% (4)33
An online database of good-practices44.1% (15)38.2% (13)17.6% (6)34
Other (please specify)
[ShowReplies]
5

10. Section 7: To be answered by Parties to the Aarhus Convention only Ratification of the GMO amendment of the Aarhus Convention Has your country already ratified the GMO amendment of the Aarhus Convention (decision II/1 on GMOs adopted by the Meeting of the Parties to the Aarhus Convention at its second session (Almaty, 25-27 May 2005)?
 AnsweredQuestion34
 
SkippedQuestion
3
 ResponsePercentResponseCount
Yes
55.9%19
No
44.1%15

Page:  
11. If you answered “no”, has your country initiated the procedure of ratification (acceptance or approval) of the amendment?[Q11]
 AnsweredQuestion15
 
SkippedQuestion
22
 ResponsePercentResponseCount
Yes
26.7%4
No
73.3%11

12. If not, what are the challenges preventing your country from initiating this procedure? Please elaborate briefly.
 AnsweredQuestion10
 
SkippedQuestion
27
 ResponseCount
[ShowReplies]10

Find...
Show replies
Hide replies